PROTEIN AND ALBUMIN CONCENTRATIONS IN ASCITIC FLUID FOR DIAGNOSIS AND PROGNOSIS OF SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENTS

Thị Thảo Nguyễn1,2, , Ngọc Ánh Trần1, Thị Mai Chi Dương1
1 Trường Đại học Y Hà Nội
2 Bệnh viện Hữu Nghị

Main Article Content

Abstract

Objectives: (1) To investigate ascitic fluid protein and albumin concentrations in cirrhotic patients with spontaneous bacterial peritonitis (SBP); (2) To evaluate their prognostic value for severity and treatment outcomes.


Methods: A cross-sectional comparative study combined with prospective follow-up of 200 cirrhotic patients with ascites (100 with SBP, 100 without) was conducted at Hanoi Medical University Hospital and Bach Mai Hospital (8/2025-6/2026). Ascitic protein, albumin and polymorphonuclear neutrophil (PMN) count were measured at diagnostic paracentesis; 30-day mortality was recorded in the SBP group.


Results: Mean age was 57.5±10.9 years; 93% were male. Ascitic protein was significantly higher in the SBP group than in the non-SBP group (13.39±7.78 vs 11.58±7.48 g/L; p=0.031); ascitic albumin showed a similar trend without reaching statistical significance (7.41±4.59 vs 6.52±4.04 g/L; p=0.095). PMN count, blood leukocytes, AST, serum sodium, Child-Pugh and MELD-Na scores differed significantly between groups (p<0.05). The AUROC of ascitic albumin for predicting 30-day mortality (n=100, 18 events) was 0.567 (95%CI: 0.443-0.688; p=0.281 vs. AUROC=0.5, DeLong test); optimal Youden cutoff was 8.6 g/L (sensitivity 94.4%, specificity 32.9%).


Conclusion: Ascitic protein was significantly higher in cirrhotic patients with SBP than without, while ascitic albumin showed only a non-significant trend in the same direction; neither marker showed prognostic value for 30-day mortality in this cohort. As protein was measured at the time of infection diagnosis, this difference likely reflects concurrent local inflammation rather than evidence for the classic hypothesis that low ascitic protein is a baseline risk factor predisposing to SBP.

Article Details

References

1. Angeli P, Bernardi M, Villanueva C, et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406-460.
2. Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by AASLD. Hepatology. 2021;74(2):1014-1048.
3. Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516-537.
4. Flower B, Hong DD, Vu Thi Kim H, Pham Minh K, Geskus RB, Day J, Cooke GS. Seroprevalence of Hepatitis B, C and D in Vietnam: a systematic review and meta-analysis. Lancet Reg Health West Pac. 2022;24:100468.
5. Furey C, Zhou S, Park JH, et al. Impact of Bacteria Types on the Clinical Outcomes of Spontaneous Bacterial Peritonitis. Dig Dis Sci. 2023;68(5):2140-2148.
6. Habib S, Ball M, Thomas C, et al. Increased Mortality with Intermediate Ascitic Polymorphonuclear Cell Counts Amongst Patients with Cirrhosis: Time to Redefine the Care Approach. Pathophysiology. 2025;32(4):62.
7. Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007;45(3):797-805.
8. Kumar D, Kumar V, Khan RTY, et al. Predictors of Mortality in Patients with Spontaneous Bacterial Peritonitis. Euroasian J Hepatogastroenterol. 2024;14(2):125-128.
9. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646-649.
10. Tay PWL, Xiao J, Tan DJH, et al. An epidemiological meta-analysis on the worldwide prevalence, resistance, and outcomes of spontaneous bacterial peritonitis in cirrhosis. Front Med (Lausanne). 2021;8:693652.